BTI
ADMA icon

Blue Trust Inc’s ADMA Biologics ADMA Stock Holding History

Blue Trust Inc’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7K Sell
1,634
-35
-2% -$319 ﹤0.01% 1771
2026
Q1 		$15K Sell
1,669
-2,600
-61% -$41K ﹤0.01% 1727
2025
Q4 		$77.9K Buy
4,269
+2,477
+138% +$41.7K ﹤0.01% 1174
2025
Q3 		$26.3K Sell
1,792
-970
-35% -$16.6K ﹤0.01% 1597
2025
Q2 		$50.3K Buy
2,762
+964
+54% +$19.7K ﹤0.01% 1454
2025
Q1 		$35.7K Buy
+1,798
New +$31.1K ﹤0.01% 1509

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Blue Trust Inc's ADMA Position: Q2 2026 in Review

Blue Trust Inc reduced its ADMA Biologics (ADMA) stake by 2.1% in Q2 2026, selling an estimated $319 and leaving 1,634 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1771.

Blue Trust Inc first reported a position in ADMA in Q1 2025 and has held it in 6 quarters since. The position peaked at $77.9K in Q4 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Blue Trust Inc held 1,634 shares of ADMA Biologics worth $13.7K as of Q2 2026.
  • Blue Trust Inc sold 35 ADMA Biologics shares in Q2 2026, an estimated $319.
  • ADMA Biologics made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1771 holding.
  • Blue Trust Inc first reported a position in ADMA Biologics in Q1 2025 and has held it in 6 quarters since.
  • Blue Trust Inc's ADMA Biologics position peaked at $77.9K in Q4 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.